Table 2.
Univariate analysis | Hazard ratio | 95 % CI | p value |
Male | 0.976 | 0.518–1.944 | 0.941 |
Age ≥ 68 | 1.070 | 0.584–1.954 | 0.825 |
PS ≥ 2 | 2.329 | 0.990–4.881 | 0.053 |
ASA-PS ≥ 2 | 1.156 | 0.623–2.179 | 0.648 |
Tubular adenocarcinoma | 0.483 | 0.231–0.935 | 0.030 |
P(+) and/or CY (+) | 0.886 | 0.448–1.913 | 0.744 |
LN(+) or H(+) | 0.970 | 0.476–1.851 | 0.928 |
Non-curative gastric resection | 0.326 | 0.172–0.614 | <0.01 |
Complications (Clavian-Dindo ≥ 2) | 1.820 | 0.832–3.679 | 0.127 |
Postoperative chemotherapy | 0.260 | 0.120–0.626 | 0.004 |
Multivariate analysis | Hazard ratio | 95 % CI | p value |
Tubular adenocarcinoma | 0.531 | 0.233–1.130 | 0.102 |
Non-curative gastric resection | 0.309 | 0.152–0.615 | <0.01 |
Postoperative chemotherapy | 0.136 | 0.056–0.353 | <0.01 |
PS performance status, ASA-PS ASA physical status